Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Sell · Filed 25/11/05

Trade details

Type: Insider sale
Amount: $12,136,239.7
Shares · price: 91,705 sh · $132.34 a share
Held after: 7,229 sh
Stock: Axsome Therapeutics AXSM
Person: Herriot TabuteauCEO
Trade date: 25/11/03
Filed: 25/11/05
Days to filing: 2 days

Sold 92.7% of holdings

Share of holding sold: 92.7%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/04~25/12/03

Herriot Tabuteau's recent trades

Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$979.2K
4,660 sh
$979.2K
Filed 08/06
Traded 08/06
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$9.6M
45,004 sh
$9.6M
Filed 08/05
Traded 08/05
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,666 sh
$12M
Filed 07/01
Traded 07/01
Herriot TabuteauCEO
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$12.2M
49,670 sh
$12.2M
Filed 06/09
Traded 06/09
Herriot TabuteauCEO
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$12M
49,670 sh
$12M
Filed 06/09
Traded 06/09

Herriot Tabuteau, CEO — sold $12.1M of Axsome Therapeutics AXSM · 92.7% of holdings · 10b5-1 plan | Whalegun